Trial Profile

Physiological Iron Maintenance in End Stage Renal Disease (ESRD) Subjects by Delivery of Soluble Ferric Pyrophosphate (SFP) Via Hemodialysate: The PRIME Study

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 07 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ferric pyrophosphate (Primary)
Indications Anaemia
Focus Therapeutic Use
Acronyms PRIME
Sponsors Rockwell Medical Technologies

Most Recent Events

28 Jun 2017 According to a Rockwell Medical India media release, data from the study will be presented in an oral presentation at the 12th Annual Conference on Nephrology & Urology 2017.
13 Jul 2015 Results published in a Rockwell Medical Technologies media release.
13 Jul 2015 Results published in Kidney International, according to a Rockwell Medical Technologies media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com